Greater transparency and independent evaluation are needed to understand the impact of the patient support programs that pharmaceutical companies offer for many expensive drugs, according to ...

About 1 in 10 prescription drugs — mainly brand-name and expensive drugs and those for rare diseases — has a manufacturer-sponsored patient support program, which usually includes financial, nursing ...

Pharmaceutical companies are undergoing a profound transformation. No longer confined to merely developing treatments, companies are assuming a partnership role to collaborate with healthcare ...

About 1 in 10 prescription drugs - mainly brand-name and expensive drugs and those for rare diseases - has a manufacturer-sponsored patient support program, which usually includes financial, nursing ...

Patients aren’t the only healthcare participants who believe self-care is necessary since the COVID-19 pandemic – 86.6% of healthcare professionals now believe so, too. However, connecting patients ...

While much attention has been given to the novel science behind cell and gene therapies (CGTs), the success of every precision medicine starts and ends with the patient. The novel science behind CGTs ...